The Developmental Core serves the multidisciplinary research mission of the UCSF-GIVI CFAR through the execution of four specific aims: 1. To support innovative research within CFAR by offering four different types of peer-reviewed funding opportunities targeting either individuals at different levels of training or investigators with a specific research/training focus. Up to five grants ($40,000/grant) in each of four distinct categories are offered annually including (1) CFAR Pilot Awards available to junior faculty or individuals transitioning to faculty status;(2) CFAR Mentored-Scientist Awards offered for postdoctoral or clinical fellows at an earlier stage in their training;(3) Basic Science Awards to laboratory-based postdoctoral fellows pursuing fundamental HIV studies and (4) International Awards ($25,000) to fund HIV-related training programs in the developing countries. 2. To conduct a comprehensive annual CFAR Mentoring Program for young HIV investigators providing each with access to the tools needed for future success in academic research. This program involves both """"""""one on one"""""""" mentoring of junior investigators by committed senior faculty members and a series of professional workshops designed to facilitate career progression and academic promotion. 3. To continue to change the pervasive academic culture of """"""""independent science"""""""" where collaboration and multidisciplinary research are embraced and new research teams can be quickly and effectively nucleated. 4. To invest strategically in a limited number of emerging research opportunities of exceptional merit or urgency. Special consideration for such investments, which are proposed by CFAR members or identified as a part of the Center's strategic planning process, is given to ideas that match a compelling opportunity with a particular internal strength within the Center. Together, these various activities of the Developmental Core are a clear expression of CFAR's commitment to the next generation of HIV investigators and are designed to ensure that their future work will be of the highest scientific and ethical quality.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI027763-19
Application #
8133770
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2010-09-01
Budget End
2011-08-31
Support Year
19
Fiscal Year
2010
Total Cost
$1,709,318
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Tymejczyk, Olga; Brazier, Ellen; Yiannoutsos, Constantin et al. (2018) HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries. PLoS Med 15:e1002534
Sauceda, John A; Lisha, Nadra E; Neilands, Torsten B et al. (2018) Cognitive-affective depressive symptoms and substance use among Latino and non-Latino White patients in HIV care: an analysis of the CFAR network of integrated clinical systems cohort. J Behav Med :
Carrico, Adam W; Cherenack, Emily M; Roach, Margaret E et al. (2018) Substance-associated elevations in monocyte activation among methamphetamine users with treated HIV infection. AIDS 32:767-771
AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord (2018) Non-Hodgkin lymphoma risk in adults living with HIV across five continents. AIDS 32:2777-2786
Martin, Maureen P; Naranbhai, Vivek; Shea, Patrick R et al. (2018) Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1. J Clin Invest 128:1903-1912
Mwimanzi, Francis; Toyoda, Mako; Mahiti, Macdonald et al. (2018) Resistance of Major Histocompatibility Complex Class B (MHC-B) to Nef-Mediated Downregulation Relative to that of MHC-A Is Conserved among Primate Lentiviruses and Influences Antiviral T Cell Responses in HIV-1-Infected Individuals. J Virol 92:
Krarup, A R; Abdel-Mohsen, M; Schleimann, M H et al. (2018) The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon. Mucosal Immunol 11:449-461
Shipley, Mackenzie M; Renner, Daniel W; Ott, Mariliis et al. (2018) Genome-Wide Surveillance of Genital Herpes Simplex Virus Type 1 From Multiple Anatomic Sites Over Time. J Infect Dis 218:595-605
Howe, Chanelle J; Dulin-Keita, Akilah; Cole, Stephen R et al. (2018) Evaluating the Population Impact on Racial/Ethnic Disparities in HIV in Adulthood of Intervening on Specific Targets: A Conceptual and Methodological Framework. Am J Epidemiol 187:316-325
Sanford, Ryan; Ances, Beau M; Meyerhoff, Dieter J et al. (2018) Longitudinal Trajectories of Brain Volume and Cortical Thickness in Treated and Untreated Primary Human Immunodeficiency Virus Infection. Clin Infect Dis 67:1697-1704

Showing the most recent 10 out of 1541 publications